Literature DB >> 21040832

Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Qiliang Cai1, Suhbash C Verma, Jie Lu, Erle S Robertson.   

Abstract

Kaposi's Sarcoma-associated Herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is the most recently identified human tumor virus,and is associated with the pathogenesis of Kaposi's sarcoma and two lymphoproliferative disorders known to occur frequently in AIDS patients-primary effusion lymphoma and multicentric Castleman disease. In the 15 years since its discovery, intense studies have demonstrated an etiologic role for KSHV in the development of these malignancies. Here, we review the recent advances linked to understanding KSHV latent and lytic life cycle and the molecular mechanisms of KSHV-mediated oncogenesis in terms of transformation, cell signaling, cell growth and survival, angiogenesis, immune invasion and response to microenvironmental stress, and highlight the potential therapeutic targets for blocking KSHV tumorigenesis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21040832      PMCID: PMC3142360          DOI: 10.1016/B978-0-12-385032-4.00003-3

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  395 in total

Review 1.  Kaposi's sarcoma.

Authors:  K Antman; Y Chang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

2.  Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Haque; J Chen; K Ueda; Y Mori; K Nakano; Y Hirata; S Kanamori; Y Uchiyama; R Inagi; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype.

Authors:  R J Biggar; D Whitby; V Marshall; A C Linhares; F Black
Journal:  J Infect Dis       Date:  2000-05-08       Impact factor: 5.226

4.  Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

Authors:  R Ravi; B Mookerjee; Z M Bhujwalla; C H Sutter; D Artemov; Q Zeng; L E Dillehay; A Madan; G L Semenza; A Bedi
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

5.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein.

Authors:  T Seo; D Lee; B Lee; J H Chung; J Choe
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

6.  KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells.

Authors:  J T Stine; C Wood; M Hill; A Epp; C J Raport; V L Schweickart; Y Endo; T Sasaki; G Simmons; C Boshoff; P Clapham; Y Chang; P Moore; P W Gray; D Chantry
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

7.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.

Authors:  N Dupin; T L Diss; P Kellam; M Tulliez; M Q Du; D Sicard; R A Weiss; P G Isaacson; C Boshoff
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha.

Authors:  C C Flowers; S P Flowers; G J Nabel
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

9.  Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men.

Authors:  N H Dukers; N Renwick; M Prins; R B Geskus; T F Schulz; G J Weverling; R A Coutinho; J Goudsmit
Journal:  Am J Epidemiol       Date:  2000-02-01       Impact factor: 4.897

10.  Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.

Authors:  L Gradoville; J Gerlach; E Grogan; D Shedd; S Nikiforow; C Metroka; G Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

View more
  63 in total

1.  Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients.

Authors:  Martina Paradžik; Viljemka Bučević-Popović; Marijan Šitum; Crystal J Jaing; Marina Degoricija; Kevin S McLoughlin; Said I Ismail; Volga Punda-Polić; Janoš Terzić
Journal:  Tumour Biol       Date:  2014-01

Review 2.  The emerging role of triple helices in RNA biology.

Authors:  Nicholas K Conrad
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-09-30       Impact factor: 9.957

3.  Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity.

Authors:  Emi Sei; Nicholas K Conrad
Journal:  Virology       Date:  2011-09-01       Impact factor: 3.616

Review 4.  Infection, mutation, and cancer evolution.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  J Mol Med (Berl)       Date:  2012-04-04       Impact factor: 4.599

Review 5.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

6.  Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.

Authors:  Fan Sun; Yadong Xiao; Zhaoxia Qu
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

7.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

8.  Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation.

Authors:  Anastasia Gelgor; Inna Kalt; Shir Bergson; Kevin F Brulois; Jae U Jung; Ronit Sarid
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

9.  H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.

Authors:  Hem Chandra Jha; Santosh Kumar Upadhyay; Mahadesh A J Prasad; Jie Lu; Qiliang Cai; Abhik Saha; Erle S Robertson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

10.  Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Zsolt Toth; Kevin F Brulois; Lai-Yee Wong; Hye-Ra Lee; Brian Chung; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.